Abelian Therapeutics
Boston · Founded 2017
About Abelian Therapeutics
Abelian Therapeutics is a biotechnology company which engages in harnessing factors in brain disease.
Company Facts
- Founded: 2017
- Legal name: Abelian Therapeutics Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jan 2017)
- Phone: 617 338-2072
Canonical: https://fsome.com/organization/abelian-therapeutics-8402714 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.